STUDY OF FIBROSIS PATHWAYS (TGF-Β AND WNT SIGNALING) AS THERAPEUTIC TARGETS IN CHRONIC KIDNEY DISEASE. (2026). MSW Management Journal, 36(1s), 2466-2470. https://doi.org/10.7492/6nvwdg38